18th December 2019
Merry Christmas from everyone at Pure Drug Safety

Merry Christmas from us all at PDS!

We would like to take a moment to wish all of our clients, colleagues and professional partners a very Merry Christmas and a healthy and Happy […]
11th December 2019
Pure Drug Safety sponsors Outstanding Achievement Award at Medilink East Midlands Business Awards

Medilink Outstanding Achievement Award 2019

Pure Drug Safety was delighted to join almost 200 business people from life science companies across the East Midlands at the 2019 Medilink East Midlands Business […]
21st November 2019
Pure Drug Safety sponsors Medilink East Midlands Outstanding Achievement Award

Pure Drug Safety Sponsor Medilink East Midlands ‘Outstanding Achievement Award’

As a trusted partner providing Pharmaceutical Solutions, we understand the complexities and difficulties surrounding the journey from innovation to the marketplace. That’s why we are proud […]
22nd July 2019

Yellow fever vaccine

Yellow fever vaccine – following two fatalities – the vaccine must not be given to patients that present with a history of thymus dysfunction, or is […]
4th April 2019

Breast Implants Safety Concerns – the Importance of Post-Marketing Surveillance

Recently, (24 March 2019), the FDA have started to scrutinise the safety of breast implants, which brings into focus the importance of post-marketing surveillance in patient […]
4th April 2019

Meeting highlights from the Pharmacovigilance Risk Assessment Committee (PRAC ) 11-15 March 2019

EU referral procedures for safety reasons: Just started – review on screening patients before treatment with fluorouracil, capecitabine, tegafur and flucytosine. The review to examine existing […]
21st March 2019

The World Tuberculosis Day – 24 March

TB is the world’s deadliest infectious killer. The disease is preventable and curable. Globally the TB mortality rate has reduced by 42% since 2000 (saving an […]